Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic agents: a clinician's perspective.

H A Solomon

    The American Journal of Medicine
    |August 24, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Thrombolytic therapy is beneficial for acute myocardial infarction by addressing intracoronary thrombosis. Despite differing clinician and researcher views, this reperfusion strategy can salvage myocardium and improve patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Letters.

    The Physician and sportsmedicine·2016
    Same author

    The importance of dental hygiene as a cancer control measure.

    The Journal of the American Dental Hygienists' Association·2010
    Same author

    Radiographic characteristics of oral tumors.

    The Penn dental journal·2010
    Same author

    Acute exacerbation of a chronic cor pulmonale.

    New York state journal of medicine·2010
    Same author

    Radiodontic diagnosis of intra-oral neoplasms; benign neoplasms.

    The Journal of the Dental Society of the State of New York·2010
    Same author

    Radiodontic diagnosis of intra-oral neoplasms; malignant neoplasms.

    The Journal of the Dental Society of the State of New York·2010
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric Panniculitis.

    The American journal of medicine·2026
    Same journal

    Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

    The American journal of medicine·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Clinical Medicine

    Background:

    • Clinicians and researchers have differing perspectives on patient data: individual vs. statistical group analysis.
    • This divergence impacts the adoption of new therapies, requiring careful consideration of individual applicability.
    • Acute myocardial infarction (AMI) presents a critical scenario where understanding these perspectives is vital for treatment decisions.

    Purpose of the Study:

    • To evaluate the role and clinical utility of thrombolytic therapy in managing acute myocardial infarction.
    • To weigh the benefits of reperfusion therapy against potential limitations and differing clinical viewpoints.

    Main Methods:

    • Clinical decision-making framework considering both supporting and limiting factors for thrombolytic therapy.
    • Focus on the pathological basis of AMI (intracoronary thrombosis) and the physiological goal of myocardial salvage through reperfusion.

    Related Experiment Videos

  • Assessment of practical aspects: administration, monitoring, and recognition of therapeutic success or failure.

    • Main Results:

    • Intracoronary thrombosis is a near-universal finding in AMI, making thrombolytic therapy a direct intervention.
    • Reperfusion via thrombolysis can limit infarct size, thereby improving prognosis by salvaging myocardial tissue.
    • Thrombolytic therapy is generally quick, easy, and safe to administer, requiring minimal lab monitoring but diligent clinical observation.

    Conclusions:

    • Despite the unsolved issue of optimal post-thrombolysis treatment, the thrombolytic component is a valuable part of AMI management.
    • The ability to salvage myocardium by limiting infarction size makes thrombolytic therapy a worthwhile intervention for clinicians.
    • Careful clinical monitoring is essential to recognize successful reperfusion and potential reocclusion events.